Group 1 - The high court ruling provides the company with renewed hope in its ongoing efforts to address long-standing litigation issues [1] - The litigation has resulted in significant financial losses for the company, amounting to billions of dollars [1]

The department-store chain's bankruptcy throws one of Amazon's biggest bets on luxury retail into doubt ...

Group 1 - The company is facing challenges and may introduce new risks by attempting to develop products based on its core plant-protein base [1]

Core Viewpoint - Bank executives are cautiously opposing President Trump's proposal to temporarily cap credit-card interest rates at 10%, while trying to avoid conflict with the White House [1] Group 1 - The banking industry is navigating a delicate balance between opposing the interest rate cap and maintaining a positive relationship with the current administration [1] - Executives are concerned that capping interest rates could impact their profitability and lending practices [1]

Group 1 - The two businesses generated about $280 million in combined revenue in 2025 [1]

RedBird's Gerry Cardinale will tell anyone who will listen why the hostile $77.9 billion bid is superior ...

Group 1 - Genco has rejected Diana's offer to acquire the company through an all-cash deal [1] - Diana holds approximately a 14.8% stake in Genco [1]

Core Viewpoint - The Federal Reserve's interest-rate policy remains "moderately restrictive" even after three quarter-point rate cuts in late 2025, indicating a continued effort to combat inflation and support economic growth [1] Group 1 - The Federal Reserve has implemented three quarter-point rate cuts in late 2025 [1] - Despite the rate cuts, the Fed's policy is still leaning against inflation [1] - The current interest-rate setting is characterized as "moderately restrictive" [1]

Core Viewpoint - FedEx Freight has secured significant financing through a five-year, $1.2 billion revolving-credit facility and a three-year, $600 million delayed-draw term-loan facility [1]. Financing Details - The revolving-credit facility amounts to $1.2 billion and has a duration of five years [1]. - The delayed-draw term-loan facility is valued at $600 million and spans three years [1].

Core Insights - The U.K. health regulator has approved a higher dose of Novo Nordisk's Wegovy weight-loss drug for patients with a body mass index (BMI) of at least 30 [1] Company Summary - Novo Nordisk's Wegovy is now available in a higher dosage, expanding its applicability to a broader range of patients [1]